Truvestments Capital’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Truvestments Capital’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$4K	Buy	+36	New	+$3.9K	﹤0.01%	766

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

Truvestments Capital's TARO Position: Q3 2018 in Review

Truvestments Capital opened a new position in Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2018: 36 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #766 among its holdings.

114 funds tracked by Wall St. Rank hold TARO as of Q3 2018.

Truvestments Capital held 36 shares of Taro Pharmaceutical Industries Ltd. worth $4K as of Q3 2018.
Taro Pharmaceutical Industries Ltd. was a new Truvestments Capital position in Q3 2018.
Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of Truvestments Capital's portfolio in Q3 2018, its #766 holding.
114 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2018.

Based on Truvestments Capital's 13F filing for Q3 2018, filed 22 Oct 2018.